BILOPTIN CAPSULES (Discontunued
2004)
SCHEDULING STATUS:
S1
PROPRIETARY NAME
(and dosage form):
BILOPTIN CAPSULES
Oral biliary contrast medium
COMPOSITION
1 capsule Biloptin contains
sodium iopodate
(sodium 3-[[(dimethylamino) methylene]amino]-2,4,6-triiodohydrocinnamate)
0,5 g, and
Methylparaben 0,04%
Propylparaben 0,02%.
PHARMACOLOGICAL CLASSIFICATION
A. 28 Contrast media.
PHARMACOLOGICAL ACTION
Biloptin is a radiodiagnostic agent and, in the recommended
doses, has no pharmacological action.
After oral administration in humans, Biloptin is rapidly and
completely absorbed. Three to four hours after intake, radiological
examinations often demonstrate only traces or none at all in the
intestine, while at the same time the gallbladder is beginning to
fill. In some cases, bile ducts can also be visualised at this time.
After enterohepatic circulation, the contrast medium is mainly
excreted by the kidneys.
INDICATIONS
Cholecystography, cholangiography.
CONTRA-INDICATIONS
Hypersensitivity to iodinated contrast media, thyrotoxicosis,
severe impairment of hepatic or renal function.
In patients with thyroid hyperfunction (whether manifest or not),
the need for the examination merits particularly careful
consideration.
DOSAGE AND DIRECTIONS FOR USE
Patients should be put on a scanty, low-residue
and non-flatulent diet 24 hours before the examination. Easily
digestible food and clear liquids, eg tea without milk or clear,
fat-free soup can be given. Eggs, rusks, fruits, oatmeal, pasta,
milk products, peas and beans, salads, smoked goods, coarse, dark or
freshly-baked bread and all vegetables are prohibited.
From 6 pm on the day before the examination, patients should refrain
from eating until after the examination the following day. Neither
should they smoke after the administration of the contrast medium,
but may drink water or weak tea if they feel thirsty.
If a laxative is prescribed, it should be taken about 20 hours
before the examination.
The 6 capsules should be swallowed whole with
plenty of water.
Unless otherwise directed by the doctor, 6 Biloptin capsules are
taken 12 hours prior to the X-ray examination (ie usually between 8
and 10 pm).
In order to attain a more intensive and longer lasting contrast 12
Biloptin capsules can be taken. These are to be taken either in one
dose the night before the examination or in 2 doses - one the
previous night and one the early morning on the day of the
examination.
Dosage and the time of administration can be varied by the doctor.
Therefore his instructions must be carefully heeded.
• Dosage for children
For children under 8 years of age the X-ray examination with
meglumine iotroxate offers the best prospects of success.
For the use of Biloptin capsules in youths the following doses are
recommended:
Children over 8 years:
| Body weight |
Number of capsules |
| 25 kg |
2 |
| 30 kg |
3-4 |
| 35 kg |
4 |
| 40 kg |
4-5 |
| 50 kg |
5-6 |
| 60 kg and more |
6 |
SIDE EFFECTS AND SPECIAL PRECAUTIONS
Sensitive patients occasionally complain about heaviness at the
pit of the stomach or nausea. Diarrhoea or vomiting occur only in
exceptional cases. Isolated cases of urticarial skin reactions have
been reported.
If allergic symptoms occur, an antihistamine or high-dose corticoids
are indicated.
Thyroid hyperfunction can increase for some time after the
examination with biliary contrast media.
If iodine isotopes are to be administered for diagnosing thyroid
disease, it should be borne in mind that following the
administration of iodine-containing biliary contrast media, the
capacity of the thyroid tissue to take up iodine is reduced for 8 to
10 weeks or longer.
Apart from the fact that X-ray examinations should, if possible, be
avoided during pregnancy, it must be pointed out that it has not yet
been proved that Biloptin may be used without hesitation in pregnant
patients. Therefore, such an examination with a contrast medium
during pregnancy should be carried out only if considered absolutely
necessary by the doctor.
Suggestions for the management of life-threatening acute
hypersensitivity reactions or acute anaphylaxis after administration
of contrast media:
Give adrenaline solution 1 mL of 1:1000 concentration (1 mg)
subcutaneously. Repeat if necessary 5 to 10 minutes later. If the
patient does not respond immediately give 0,1-0,4 mL of 1:1000
concentration diluted in 10 mL physiological saline intravenously
SLOWLY.
Maintain an open airway. An emergency tracheostomy may be necessary.
Positive pressure oxygen administration may be required.
In the event of urticaria or angio-oedema, administer adrenaline
subcutaneously followed by an antihistamine intravenously (eg
diphenhydramine hydrochloride 20 mg).
For prolonged or severe reactions give hydrocortisone sodium
succinate 250 mg or methylprednisolone sodium succinate 100 mg
intravenously over 30 seconds after adrenaline and the
antihistamine.
Aminophylline injection 250-500 mg should be given slowly
intravenously in the presence of bronchospasm.
Intravenous fluids may be required to correct hypovolemia.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT
If three to four times the normal dose of 6 capsules is taken
within 12 hours, the symptoms described under "Side effects and
special precautions" may occur. Allergic symptoms should be treated
with an antihistamine or high-dose corticoids.
IDENTIFICATION
Long, ochre, soft gelatine capsules containing a
yellowish-white, oily paste. The capsules may be imprinted with a
black "B" in a regular hexagon.
PRESENTATION
20 x 6 capsules.
STORAGE INSTRUCTIONS
In original packs at room temperature, below 30°C. Keep out of
reach of children.
REFERENCE NUMBER
H.2840 (Act 101/1965)
NAME AND BUSINESS ADDRESS OF THE APPLICANT
Schering (Pty) Ltd
(Reg No: 64/09072/07)
106 Sixteenth Road
Randjespark
Midrand 1685
P O Box 5278
Halfway House 1685
DATE OF PUBLICATION OF THIS PACKAGE INSERT
6 February 1979
SCHERING (PTY) LTD
(Reg No: 64/09072/07)
Subsidiary of
Schering AG Germany
New addition to this site: January 2002
Information presented by Malahyde Information
Systems © Copyright 1996-2000
|